We develop innovative gene and cell therapies with a profound impact on people's lives.

About us

We are guided by 4 core principles

Our priority is to help as many people as possible.
-
Our focus is to create treatments that are safe and effective.
-
Our objective is to have an impact on the lives of people that are at a higher risk of developing gene-related diseases.
-
Our technologies are developed by carefully studying solutions already available in nature.
-

Genetic diseases

At PeterBio we want to make nature’s solutions to genetic diseases available through our RITDM™ technology. In nature, specific genes can exist in multiple variants, some of which can be causing diseases, but they can also be protective or leading to milder symptoms. One example is that we are working on the apoE gene, which exists in a number of variants that can be protective against, but also increasing the risk of Alzheimer’s disease.

Inspiration

PeterBio is inspired by and dedicated to individuals that play an important role in our lives. Our family and friends, a number of whom suffer from, or are worried about, genetic disadvantages, diabetes, Alzheimer’s, Parkinson’s, cancer and CF. Peter is one of them. PeterBio signifies that our work is all about people.

Meet the Team

Dirk
Hondmann
Chief Executive Officer
Dirk is an experienced senior executive who brings more than 25 years of R&D and Innovation Management to the team. Dirk holds a PhD in Molecular Genetics.
Read More
Chenzhong
Kuang
Chief Scientific Officer
Chenzhong has over 15 years experience in R&D and innovation, with a focus on genome medicine, molecular biology, and neural sciences. He holds MD and PHD degrees in Medical and Molecular Genetics.
Read More
Yan
Xiao
Senior Vice President Discovery
Yan has expertise in cellular and molecular biology, cell engineering and medicine for more than 20 years. She holds a MD in Endocrinology.
Read More
George
Westerkamp
Board Member
George has over 20 years of experience in private equity and venture capital, including healthcare, pharma and life science investing. He holds an MSc in Business Economics.
Read More
Stuart
Orkin
Scientific Advisory Board
Stuart Orkin is the David G. Nathan Distinguished Professor of Pediatrics at Harvard Medical School, a member of the National Academy of Sciences and the Institute of Medicine, and a Howard
Read More

We use cookies to personalize our service and to improve your experience on the website. We also use thus information for analytics.